Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contrast-enhanced MRI improves the diagnostic performance for vaginal fornix invasion in cervical carcinoma.

Insights into imaging·2026
Same author

Stimuli-responsive copper-iodide nanoparticles for low-dose X-ray-induced photodynamic therapy and enhanced cuproptosis.

Acta biomaterialia·2026
Same author

Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Prognostic value of LPAR1 expression and methylation in low-grade gliomas: a meta-analysis of TCGA and CGGA datasets and functional validation.

BMC cancer·2025
Same author

Fruquintinib plus sintilimab in patients with advanced endometrial cancer with mismatch-repair proficient status: a multicenter, single-arm, phase Ib/II trial.

Nature communications·2025
Same author

Targeting OxLDL-mediated CD36 + CAF reprogramming potentiates PD-1 immunotherapy in osteosarcoma.

Molecular cancer·2025

Related Experiment Video

Updated: May 7, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Nanoparticles for Improving Cancer Diagnosis.

Hongmin Chen1, Zipeng Zhen, Trever Todd

  • 1Department of Chemistry and Bio-Imaging Research Center, University of Georgia, 1001 Cedar Street, Athens, GA 30602.

Materials Science & Engineering. R, Reports : a Review Journal
|September 27, 2013
PubMed
Summary

Early cancer detection is crucial for effective treatment. Nanotechnology offers sensitive nanoparticle-based probes for early diagnosis, improving patient outcomes.

Keywords:
bioconjugationbiomarkerscancer diagnosisimagingnanomedicinenanotechnologysurface modification

More Related Videos

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Fabrication of Spherical and Worm-shaped Micellar Nanocrystals by Combining Electrospray, Self-assembly, and Solvent-based Structure Control
06:16

Fabrication of Spherical and Worm-shaped Micellar Nanocrystals by Combining Electrospray, Self-assembly, and Solvent-based Structure Control

Published on: February 11, 2018

Related Experiment Videos

Last Updated: May 7, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Fabrication of Spherical and Worm-shaped Micellar Nanocrystals by Combining Electrospray, Self-assembly, and Solvent-based Structure Control
06:16

Fabrication of Spherical and Worm-shaped Micellar Nanocrystals by Combining Electrospray, Self-assembly, and Solvent-based Structure Control

Published on: February 11, 2018

Area of Science:

  • Nanomedicine
  • Biotechnology
  • Molecular Diagnostics

Background:

  • Cancer remains a leading cause of mortality, often due to late-stage diagnosis.
  • Metastasis at diagnosis significantly complicates or prevents effective cancer therapies.
  • Early or pre-syndrome stage diagnosis is critical for improving treatment success.

Purpose of the Study:

  • To review the advancements in nanotechnology for cancer diagnostics.
  • To highlight the development and engineering of "smart" nanoprobes.
  • To emphasize the role of nanotechnology in early cancer detection and management.

Main Methods:

  • Utilizing nanoparticles as highly sensitive detection tags.
  • Coupling nanoparticles with targeting molecules for specific biological interaction.
  • Developing nanoparticle-based probes for molecular-level sensing.
  • Engineering nanoprobes for enhanced diagnostic accuracy.

Main Results:

  • Nanoparticles exhibit unique properties suitable for sensitive diagnostic tags.
  • Nanoparticle-based probes enable accurate molecular-level sensing of biological changes.
  • Significant progress has been made in applying nanotechnology to clinical imaging and diagnostics.
  • Interdisciplinary efforts are impacting clinical cancer management.

Conclusions:

  • Nanotechnology provides a powerful platform for developing advanced cancer diagnostic tools.
  • Smart nanoprobes offer unprecedented sensitivity and accuracy for early cancer detection.
  • Continued development in nanotechnology is essential for improving cancer diagnosis and patient survival rates.